Product Profile: WINREVAIR (sotatercept-csrk, for injection, for subcutaneous use)
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Early trial of linvoseltamab shows promise for newly diagnosed multiple myeloma patients | ASH 2025
2
Findings suggest linvoseltamab could be a useful new option for new multiple myeloma patients | ASH 2025
3
IV iron treatment improves survival, increases hemoglobin levels in anemic patients with acute bacterial infection | ASH 2025
4
Gene therapy in the real world: High priced, a long process and still relatively few patients | ASH 2025
5
